Squamous Cell Carcinoma of Unknown Primary: Clinical Trials

1 trial for Squamous Cell Carcinoma of Unknown Primary, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

1 recruiting. 1 Phase 1.

By phase and status

PhaseTrialsStatus
Phase 11Recruiting 1

Follow Squamous Cell Carcinoma of Unknown Primary: new trials by email Literature Review of Squamous Cell Carcinoma of Unknown Primary trials Research Report on Squamous Cell Carcinoma of Unknown Primary

Trials (filtered) newest first · largest first

All 1 trial

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
TMV Vaccine Therapy Alone and With Pembrolizumab for the Treatment of Recurrent and/or Metastatic Head and Neck Squamous Cell Cancer
Autologous Tumor Membrane Vesicles Vaccine, Biospecimen Collection, Computed Tomography - Clinical Stage IV HPV-Mediated (p16-Positive) Oropharyngeal Carcinoma AJCC v8, Metastatic Head and Neck Squamous Cell Carcinoma
Phase 1RecruitingEmory University402025-05-082026-03-04

Narrower conditions

Carcinoma (1)  ·  Hypopharyngeal Neoplasms (1)  ·  Laryngeal Neoplasms (1)  ·  Mouth Neoplasms (1)  ·  Nasopharyngeal Carcinoma (1)  ·  Oropharyngeal Neoplasms (1)  ·  Recurrence (1)  ·  Squamous Cell Carcinoma of Head and Neck (1)

Broader conditions

Carcinoma, Squamous Cell (1)  ·  Disease Attributes (1)  ·  Head and Neck Neoplasms (1)  ·  Laryngeal Diseases (1)  ·  Mouth Diseases (1)  ·  Nasopharyngeal Diseases (1)  ·  Nasopharyngeal Neoplasms (1)  ·  Neoplasms (1)  ·  Neoplasms by Histologic Type (1)  ·  Neoplasms by Site (1)  ·  Neoplasms, Glandular and Epithelial (1)  ·  Otorhinolaryngologic Diseases (1)  ·  Otorhinolaryngologic Neoplasms (1)  ·  Pathologic Processes (1)  ·  Pathological Conditions, Signs and Symptoms (1)

Interventions

Magnetic Resonance Spectroscopy (1)  ·  Specimen Handling (1)  ·  Surgical Procedures, Operative (1)  ·  pembrolizumab (1)

Sponsors

Emory University (1)

Countries

United States (1)

Top investigators

Dong M. Shin, MD, FACP, FAAAS (1)

NIH funding

P30CA138292 (1), R01CA262123 (1)